Dolby (DLB) director Emily Rollins receives 3,908 RSUs in stock grant

Rhea-AI Filing Summary

Dolby Laboratories director Emily Rollins received an equity grant as part of her board compensation. On February 3, 2026, she was awarded 3,908 restricted stock units of Class A common stock at a price of $0 per share under Dolby’s 2020 Stock Plan.

Each unit represents one share that will vest on the earlier of the first anniversary of the grant date or the date immediately preceding Dolby’s 2027 annual stockholder meeting, as long as she continues serving on the board. After this grant, she beneficially owns 13,541 Class A shares, including the unvested units, which remain subject to forfeiture until they vest.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Rollins Emily

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	3,908	$0.00	--

Holdings After Transaction: Class A Common Stock — 13,541 shares (Direct)

Footnotes (1)

1. Award represents a total of 3,908 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2027 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date. Shares held following the reported transactions include 3,908 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rollins Emily

(Last) (First) (Middle)

C/O DOLBY LABORATORIES, INC.

1275 MARKET STREET

(Street)

SAN FRANCISCO CA 94103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Dolby Laboratories, Inc. [ DLB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	02/03/2026		A		3,908	A(1)	$0	13,541(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Award represents a total of 3,908 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2027 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date.

2. Shares held following the reported transactions include 3,908 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.

	/s/ Daniel Rodriguez as Attorney-in-Fact for Emily Rollins	02/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Dolby Laboratories (DLB) report for Emily Rollins?

Dolby reported that director Emily Rollins received 3,908 restricted stock units of Class A common stock on February 3, 2026. The grant was made at $0 per share under the company’s 2020 Stock Plan as part of her director compensation.

When do Emily Rollins’s new Dolby (DLB) restricted stock units vest?

The 3,908 restricted stock units will vest on the earlier of the first anniversary of the February 3, 2026 grant date or the date immediately preceding Dolby’s 2027 annual stockholder meeting, provided Emily Rollins continues serving on the board on that date.

How many Dolby (DLB) shares does Emily Rollins beneficially own after this Form 4?

After the reported transaction, Emily Rollins beneficially owns 13,541 shares of Dolby Class A common stock. This total includes the 3,908 shares underlying restricted stock units that are unvested and remain subject to potential forfeiture until they vest.

Are Emily Rollins’s new Dolby (DLB) restricted stock units immediately transferable?

No. The 3,908 restricted stock units are subject to vesting conditions and forfeiture risk. They represent a contingent right to receive Dolby Class A shares and will only convert into shares once the specified vesting date or event is reached.

What plan governs Emily Rollins’s new Dolby (DLB) equity award?

The award of 3,908 restricted stock units to Emily Rollins was granted under Dolby’s 2020 Stock Plan. Each unit corresponds to one share of Dolby Class A common stock, subject to continued board service through the applicable vesting date described in the grant terms.